⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5019061 | 1.00 | — | — | |
| SCHEMBL27165475 | 1.00 | KDM4E (0.38) | — | |
| SCHEMBL12914613 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL9391298 | 0.97 | KDM4E (0.37) | — | |
| SCHEMBL27165474 | 0.82 | GGT1 (0.35) | — | |
| SCHEMBL10122856 | 0.80 | — | — | |
| SCHEMBL18095151 | 0.80 | — | — | |
| SCHEMBL29805658 | 0.80 | — | — | |
| SCHEMBL13035654 | 0.79 | — | — | |
| SCHEMBL19849408 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1607 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12599655-B2 | Neisseria gonorrhoeae vaccine compositions and methods of selecting antigens | TRUSTEES OF TUFTS COLLEGE | 2026-04-14 | — | — | US | claimed |
| US-20260071989-A1 | SINGLE-STRANDED DNA MOLECULAR RECOGNITION ELEMENTS AGAINST CYANOTOXIN L-BMAA | UNIV PUERTO RICO (US) | 2026-03-12 | — | — | US | claimed |
| EP-4583908-A2 | LIVE SALMONELLA TYPHI VECTORS ENGINEERED TO EXPRESS CANCER PROTEIN ANTIGENS AND METHODS OF USE THEREOF | University of Maryland, Baltimore (US) | 2025-07-16 | — | — | EP | claimed |
| CN-120060366-A | Preparation method of ATP7B gene editing somatic cells of Bama miniature pigs | 安徽农业大学 | 2025-05-30 | — | — | CN | claimed |
| WO-2025109003-A1 | P-CADHERIN LIGANDS | 3B PHARMACEUTICALS GMBH (DE) | 2025-05-30 | — | — | WO | claimed |
| CN-120036276-A | Construction and evaluation method of pig retina pigment degeneration disease model | 广州湾区生物医药研究院 | 2025-05-27 | — | — | CN | claimed |
| CN-118562924-B | Construction method and application of melanin evaluation model | 曼秀雷敦(中国)药业有限公司 | 2025-05-16 | — | — | CN | claimed |
| CN-222864108-U | Sealing device of Bama pig underwater monitor and monitor | 中国人民解放军海军特色医学中心 | 2025-05-13 | — | — | CN | claimed |
| CN-115961362-B | Uniform oiling device of Bama lattice winding equipment | 浙江瑞盛科新材料研究院有限公司 | 2025-05-06 | — | — | CN | claimed |
| CN-119899241-A | Antibacterial peptide of targeting BamA and preparation method and application thereof | 重庆理工大学 | 2025-04-29 | — | — | CN | claimed |
| CN-114216996-A | Method for predicting health of pesticide application personnel by using in-vitro transdermal test | 苏州西山中科药物研究开发有限公司 | 2022-03-22 | — | — | CN | claimed |
| CN-114181944-A | Mutant gene and use thereof | 中国科学院动物研究所 | 2022-03-15 | — | — | CN | claimed |
| CN-114181886-A | Application of three-dimensional culture system in intestinal epithelial organoids of Bama pigs and cynomolgus monkeys | 清华大学 | 2022-03-15 | — | — | CN | claimed |
| CN-114180777-A | Active water with efficacy of reducing high blood pressure, high blood sugar and high blood lipid and production process thereof | 李晓军 | 2022-03-15 | — | — | CN | claimed |
| WO-2022046997-A1 | BAMA-BINDING AGENTS AND METHODS OF USE THEREOF | NGM BIOPHARMACEUTICALS, INC. (US) | 2022-03-03 | — | — | WO | claimed |
| EP-2782566-B1 | L-SERINE AS FOR USE IN TREATING NEURODEGENERATIVE DISORDERS | THE INST FOR ETHNOMEDICINE (US) | 2021-01-06 | — | — | EP | claimed |
| US-20180027781-A1 | L-SERINE COMPOSITIONS, METHODS AND USES FOR TREATING NEURODEGENERATIVE DISEASES AND DISORDERS | THE INSTITUTE FOR ETHNOMEDICINE (US) | 2018-02-01 | — | — | US | claimed |
| EP-2782566-A1 | L-SERINE COMPOSITIONS, METHODS AND USES FOR TREATING NEURODEGENERATIVE DISEASES AND DISORDERS | The Institute for Ethnomedicine (US) | 2014-10-01 | — | — | EP | claimed |
| US-20130156846-A1 | L-SERINE COMPOSITIONS, METHODS AND USES FOR TREATING NEURODEGENERATIVE DISEASES AND DISORDERS | THE INSTITUTE FOR ETHNOMEDICINE (US) | 2013-06-20 | — | — | US | claimed |
| WO-2013078395-A1 | L-SERINE COMPOSITIONS, METHODS AND USES FOR TREATING NEURODEGENERATIVE DISEASES AND DISORDERS | THE INSTITUTE FOR ETHNOMEDICINE (US) | 2013-05-30 | — | — | WO | claimed |